Telemedicine projects

IGES Institute

15 success factors for telemedicine projects

A type of checklist is to make telemedicine projects more successful in future. IGES experts have determined 15 success factors which providers of innovative telemedicine services can already take into consideration in the early stages of development. Using these factors, innovators can test whether their product is suited to the current market situation, is financeable, meets the required benefit and quality standards and corresponds to patient needs. » Details

IGES Institute

IGES Institute

Self-driving buses: practical tests conducted in Brandenburg

To date, experience with autonomously driven buses in the public transport sector has been scarce. A pilot project in a rural area in Brandenburg aims to change this. The IGES Institute is supervising this project scientifically. » Details

Drug Atlas 2017

IGES Institute

New website launched for Drug Atlas 2017

The current issue of Drug Atlas has been published in a new web design. The aim of the relaunch is to present important ambulatory data with regard to the German pharmaceutical market even more clearly and user-friendly by means of advanced search functions and lexical presentations. For over ten years, the Drug Atlas has been delivering structured information on drug use and corresponding expenditures of the statutory health insurance (GKV). » Details

Digital care

IGES Institute

Lack of networking in the healthcare sector prevents digital care

Three out of four nursing care services do yet not document electronically. Reported reasons for this were especially the obligation to document on paper, leading to double documentation, as well as the generally poor networking in the healthcare sector. This was shown by an IGES study conducted on behalf of the Federal Ministry for Economic Affairs and Energy (BMWi). » Details

Breast cancer

IGES Institute

Further improving care of women with metastasized breast cancer

Approximately 72,000 women in Germany are confronted with a breast cancer diagnosis each year. Almost every fourth women develops metastasis. Generally, these women can no longer be cured and usually die within a few years. Experts call for focusing more on their needs, as had been discussed on the occasion of a healthcare conference jointly hosted by the IGES Institute and the pharmaceutical company Novartis on 9 November. Practice and hospital based doctors as well as representatives from health insurances, politics and patients participated. » Details

ISPOR 2017

IGES Institute

IGES at the ISPOR Health Economics Congress

IGES experts provided insights into current questions in health economics in Germany at the International Society for Pharmacoeconomics and Outcomes Research’s (ISPOR) European Congress in Glasgow, Scotland. Topics presented included studies on selected diseases and analyses of benefit assessments of pharmaceuticals. » Details

Bio Europe 2017

IGES Institute

Reimbursement procedures for pharmaceuticals remain challenging

Experts have rated positive European efforts to harmonize individual EU countries’ health technology assessment (HTA) systems for pharmaceuticals. However, standardized reimbursement procedures and subsequent standardized market access still cannot be expected. » Details

IGES Competence Center Innovation Fund

  • Using systematic benefit assessment to find the best project for the Innovation Fund
  • New dimensions in health care research
  • Planing Innovation Fund projects now
  • Thought-provoking impulse: import of innovative care concepts
Hirndoping
AiM

AiM

Assessment in Medicine

Evidence based reimbursement of medical devices » Details

CSG

CSG

Clinical Study Group

Clinical research that doesn't lose sight of the big picture » Details

IMC clinicon

IMC clinicon

IMC clinicon

Analysis and consulting for hospitals » Details

HealthEcon

HealthEcon

Optimizing Market Access

Swiss consulting since 1981 » Details